Physician profile
Ralph Caselnova
NPI 1548219835
$16,304.13
in general payments reported to CMS, 2019-2025
48 companies · $2,262 in 2025
The $2,262 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,716 · 2020: $1,853 · 2021: $1,722 · 2022: $3,439 · 2023: $2,452 · 2024: $1,860 · 2025: $2,262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,574.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,076.75 | 2019-2025 | Dragonfly Opstar, Mitraclip, Optis |
| Janssen Pharmaceuticals, INC | $1,421.80 | 2019-2024 | Xarelto |
| Inari Medical, INC. | $1,151.54 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $1,147.74 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,053.42 | 2019-2025 | |
| Novo Nordisk INC | $776.24 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $760.54 | 2019-2025 | |
| Medtronic Vascular, INC. | $668.03 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $558.66 | 2019-2025 | Uptravi, Opsumit |
| Medtronic, INC. | $549.58 | 2021-2025 | Corevalve Evolut R, Azure Xt Dr Mri Surescan, Micra |
| Pfizer INC. | $549.38 | 2019-2025 | |
| Kestra Medical Technology Services, INC. | $492.35 | 2022-2025 | Assure Wcd |
| Esperion Therapeutics, INC. | $484.40 | 2020-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $426.71 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $402.05 | 2019-2025 | Camzyos, Eliquis |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $394.93 | 2021-2025 | Impella |
| Merck Sharp & Dohme LLC | $387.87 | 2021-2025 | Verquvo |
| Boston Scientific Corporation | $322.03 | 2019-2025 | Watchman Flx, Watchman Access System |
| Astrazeneca Pharmaceuticals Lp | $290.99 | 2019-2023 | Farxiga |
| Edwards Lifesciences Corporation | $286.00 | 2020-2023 | Sapien 3 Ultra Resilia |
| Sanofi-Aventis U.S. LLC | $278.14 | 2019-2024 | |
| Siemens Medical Solutions USA, INC. | $169.88 | 2022-2023 | Acuson Redwood Diagnostic Ultrasound System |
| Lilly USA, LLC | $156.50 | 2019-2025 | Zepbound, Mounjaro |
| Cardiovascular Systems INC. | $138.64 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $121.51 | 2019-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $113.12 | 2024 | Arcalyst |
| Endologix LLC | $108.27 | 2025 | Endocross Device, Torus Stent Graft System |
| Regeneron Healthcare Solutions, INC. | $105.26 | 2019-2024 | Evkeeza |
| Chiesi USA, INC. | $96.15 | 2020-2023 | Cleviprex, Kengreal |
| Cvrx, INC. | $81.46 | 2024-2025 | Barostim Neo System |
| Kiniksa Pharmaceuticals, Ltd. | $76.18 | 2023 | Arcalyst |
| Lundbeck LLC | $68.27 | 2019-2020 | |
| Penumbra, INC. | $62.13 | 2025 | Indigo System |
| Arbor Pharmaceuticals, INC. | $56.21 | 2019-2021 | |
| Bardy Diagnostics, INC. | $54.74 | 2020 | |
| Daiichi Sankyo INC. | $49.57 | 2022-2024 | Injectafer |
| Heartflow, INC. | $48.55 | 2022-2024 | |
| Scpharmaceuticals INC. | $47.17 | 2024-2025 | |
| Shockwave Medical, INC | $41.35 | 2021-2022 | |
| Althera Pharmaceuticals LLC | $38.53 | 2021 | |
| Angiodynamics, INC. | $32.18 | 2024 | Auryon Laser System 100-120 Vac |
| Avinger INC. | $30.00 | 2022 | |
| Baxter Healthcare | $26.73 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Lexicon Pharmaceuticals, INC. | $25.70 | 2023 | Inpefa |
| Ionis Pharmaceuticals, INC. | $22.91 | 2025 | Tryngolza |
| Inspire Medical Systems, INC. | $22.80 | 2024 | Inspire |
| Vifor Pharma, INC. | $18.08 | 2019 | |
| Gilead Sciences, INC. | $13.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Caselnova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.